illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. Meinian Onehealth Healthcares
Company logo

Meinian Onehealth Healthcares | Sustainability Performance

www.health-100.cn

Provider of medical examination, health management, and diagnostic services.

1991

China

10,001+ employees

Hospital & Health Care

$1B - 10B in revenue

$25M - 100M in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#11597
Overall
#724
in China
#131
in Hospital & Health Care

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

128 out of 148

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
BioKangtai

China, Health Care, Biotechnology


Company logo
Shandong Buchang Pharmaceuticals

China, Health Care, Pharmaceuticals


Company logo
INT Medical Instruments

China, Health Care, Medical Device

Market cap

20.8B $, 2026▼1.7% YoY

Revenue

10.7B $, 2024▲1.8% YoY

R&D intensity

0.47% 2024

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Meinian Onehealth Healthcare Holdings Co Ltd, Chinese private health checkup chain, has faced sustained Chinese NHC enforcement scrutiny over alleged inadequate disclosure of Chinese health checkup service quality at multiple operations, plus the contested 2024 sustained share price volatility amid Chinese health checkup customer demand normalization affecting Chinese institutional minority shareholders.
Powered by illuminem

Market cap

20.8B $, 2026▼1.7% YoY

Revenue

10.7B $, FY2024▲1.8% YoY

EBITDA

1.0B $, FY2024▼9.1% YoY

Operating margin

9% Industry: 9▲24.4% YoY

P/E ratio

63.7 Industry: 23▼27.4% YoY

Revenue & EBITDA

$10.7BFY2024 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

1.2B 2024▲32.9% YoY

Capex

445.0M 2024▼8.5% YoY

Debt/equity ratio

0.9 Industry: -2▼NaN% YoY

R&D intensity

0.5%FY2024

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

2.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

8.6

▼ 11.7%

2022

10.9

▲ 0.8%

2023

10.7

▼ 5.6%

2024

14.3

2027

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Available

Human rights policy

Available

Recycling policy

Not available

Workplace health & safety policy

Not available

25%
Independent Directors

3 out of 12 incl. management

Powered by illuminem

Overall score

43

Environment

21

Social

48

Governance

61

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Not committed to key sustainability initiatives

Sustainability employees


    Available in
    Scale package

    Access
  • Email

  • Email